This report contains market size and forecasts of Penicillin/Streptomycin in global, including the following market information:
Global Penicillin/Streptomycin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Penicillin/Streptomycin Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Penicillin/Streptomycin companies in 2021 (%)
The global Penicillin/Streptomycin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Penicillin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Penicillin/Streptomycin include Johnson & Johnson, Pfizer, Bayer HealthCare, Abbot Laboratories, Roche Pharmaceuticals, Sanofi Aventis, Takeda Pharmaceutical Company, Toyama Chemical and Merck & Co., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Penicillin/Streptomycin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Penicillin/Streptomycin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Penicillin/Streptomycin Market Segment Percentages, by Type, 2021 (%)
Penicillin
Streptomycin
Global Penicillin/Streptomycin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Penicillin/Streptomycin Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Penicillin/Streptomycin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Penicillin/Streptomycin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Penicillin/Streptomycin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Penicillin/Streptomycin revenues share in global market, 2021 (%)
Key companies Penicillin/Streptomycin sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Penicillin/Streptomycin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Pfizer
Bayer HealthCare
Abbot Laboratories
Roche Pharmaceuticals
Sanofi Aventis
Takeda Pharmaceutical Company
Toyama Chemical
Merck & Co.
MiddleBrook Pharmaceuticals
Novartis
Biogen IDEC
Bristol Myers Squibb
Celgine Corporation
Eli Lilly and Co
Gilead Sciences
GlaxoSmithKline
Amgen
Astellas Pharma
Astra Zeneca